Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001881431-24-000001
Filing Date
2024-12-11
Accepted
2024-12-11 13:45:15
Documents
1
Effectiveness Date
2024-12-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8210
  Complete submission text file 0001881431-24-000001.txt   9258
Mailing Address 34391 TUPELO STREET FREMONT CA 94555
Business Address 34391 TUPELO STREET FREMONT CA 94555 650 703-2498
Aarvik Therapeutics, Inc. (Filer) CIK: 0001881431 (see all company filings)

EIN.: 852895031 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-531747 | Film No.: 241541112